Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor97

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor44

Views

Views
December 20255
January 20264
February 20262
March 20266
April 20263
May 202614
June 202610
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States20
United Kingdom4
Netherlands4
Chile4
Canada2
Argentina1
Brazil1
Switzerland1
Colombia1
Ecuador1
 

Top cities views

Views
San Jose4
Groningen4
Ashburn2
Brooklyn1
Charlotte1
Helsinki1
Ibagué1
Kingston1
La Calera1
Las Vegas1